GDOC
ยทARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
21.42MUSD
Fund Flows (1Y)
-809.50KUSD
Dividend Yield
0.02%
Discount/Premium to NAV
-0.23%
Shares Outstanding
600.00K
Expense Ratio
0.75%
About Goldman Sachs Future Health Care Equity ETF
Issuer
Goldman Sachs Asset Management, L.P.
Brand
Goldman Sachs
Inception Date
Nov 9, 2021
Structure
Open-Ended Fund
Index Tracked
--
Management Style
Active
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
Goldman Sachs Asset Management LP
Distributor
ALPS Distributors, Inc.
GDOC targets innovators and disruptors in the healthcare sector by looking for companies that are developing new treatments and technologies, primarily in the following key themes: genomics, precision medicine, tech-enabled procedures, and digital healthcare. Eligible companies are not required to derive any current or future revenue from healthcare innovation. GDOC may invest in foreign issuers and in any market capitalization. It may use other funds, futures, forwards, and options to gain its desired exposure. The fund's key themes and their respective allocations may vary over time, depending on the fund adviser's discretion. The fund adviser utilizes a fundamental investment process that may integrate ESG factors with fundamental metrics. Company disclosure, third-party research, engagement with companies, and subjective criteria are used by the fund adviser to form investment decisions.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Health Care Technology
Strategy
Active
Geography
Global
Weighting Scheme
Proprietary
Selection Criteria
Proprietary
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -3.77% | +7.90% | +9.56% | +10.28% | +12.26% | -8.98% |
NAV Total Return | -2.48% | +8.44% | +10.42% | +10.63% | +14.85% | -0.19% |
Ratings
No data is currently available
Ainvestโs AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investorsโtransforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region

85.7%
11.37%
2.93%
Category
Ratio
North America
85.70%
Europe
11.37%
Asia
2.93%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Growth
Comprises companies of multiple sizes that have high growth potential. These ETFs focus on firms across different market caps with promising growth prospects.
Top 10 Holdings
Symbol
Ratio
LLY
Eli Lilly
12.47%
BSX
Boston Scientific
6.84%
JNJ
Johnson & Johnson
6.35%
TMO
Thermo Fisher
5.67%
ASTRAZENECA PLC ORD
5.66%
ISRG
Intuitive Surgical
5.06%
ABT
Abbott Laboratories
4.68%
ARGX
argenx
3.95%
PODD
Insulet
3.46%
GH
Guardant Health
3.39%
Top 10 Weight 57.53%
44 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2024-12-23 | 2024-12-23 | 2024-12-30 | 0.006 |
| 2023-12-26 | 2023-12-27 | 2024-01-02 | 0.179 |
| 2022-09-26 | 2022-09-27 | 2022-09-30 | 0.000 |
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
